Payment overview · 2025
General Payments
$57.46
3 reported records · 3 companies
Healthcare provider profile · identity verified
Stephen Gabriel Kuruc, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · STEUBENVILLE, OH · NPI 1609867258
Verified facts
What the public records show
CMS Open Payments records show Stephen Gabriel Kuruc, M.D. received $57.46 in general payments during 2025 across 3 reported records.
Boston Scientific Corporation accounted for 50.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $28.99 | 50.5% | 1 | 2025 |
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $14.55 | 25.3% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $13.92 | 24.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $57.46 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| WATCHMAN Access System Normalized: watchman access system |
Device | Boston Scientific Corporation | $28.99 | 1 | 2025 |
Source payment records
|
|||||
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $14.55 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $13.92 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $13.92 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1045 | 209 |
| Levothyroxine Sodium | Levothyroxine Sodium | 993 | 172 |
| Potassium Chloride | Potassium Chloride | 739 | 149 |
| Lisinopril | Lisinopril | 619 | 142 |
| Pantoprazole Sodium | Pantoprazole Sodium | 611 | 116 |
| Amlodipine Besylate | Amlodipine Besylate | 509 | 98 |
| Furosemide | Furosemide | 476 | 87 |
| Omeprazole | Omeprazole | 440 | 86 |
| Metoprolol Tartrate | Metoprolol Tartrate | 427 | 85 |
| Sertraline Hcl | Sertraline Hcl | 407 | 67 |
| Gabapentin | Gabapentin | 383 | 55 |
| Eliquis | Apixaban | 366 | 55 |
| Simvastatin | Simvastatin | 335 | 74 |
| Allopurinol | Allopurinol | 304 | 47 |
| Metformin Hcl | Metformin Hcl | 297 | 69 |
| Buspirone Hcl | Buspirone Hcl | 270 | 51 |
| Trazodone Hcl | Trazodone Hcl | 258 | 52 |
| Clopidogrel | Clopidogrel Bisulfate | 252 | 49 |
| Lorazepam | Lorazepam | 250 | 59 |
| Carvedilol | Carvedilol | 215 | 41 |
| Losartan Potassium | Losartan Potassium | 214 | 40 |
| Hydrochlorothiazide | Hydrochlorothiazide | 210 | 48 |
| Meloxicam | Meloxicam | 206 | 48 |
| Metoprolol Succinate | Metoprolol Succinate | 203 | 44 |
| Tamsulosin Hcl | Tamsulosin Hcl | 199 | 35 |
| Oxycodone Hcl | Oxycodone Hcl | 195 | 30 |
| Tramadol Hcl | Tramadol Hcl | 185 | 47 |
| Montelukast Sodium | Montelukast Sodium | 183 | 33 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 159 | 67 |
| Memantine Hcl | Memantine Hcl | 157 | 31 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 151 | 32 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 147 | 27 |
| Januvia | Sitagliptin Phosphate | 138 | 16 |
| Donepezil Hcl | Donepezil Hcl | 135 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 131 | 24 |
| Famotidine | Famotidine | 120 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 118 | 98 |
| Synthroid | Levothyroxine Sodium | 116 | 23 |
| Escitalopram Oxalate | Escitalopram Oxalate | 115 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 115 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 112 | 21 |
| Ezetimibe | Ezetimibe | 111 | 24 |
| Glimepiride | Glimepiride | 107 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 106 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 105 | 22 |
| Mirtazapine | Mirtazapine | 102 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 94 | 16 |
| Spironolactone | Spironolactone | 94 | 14 |
| Alendronate Sodium | Alendronate Sodium | 85 | 20 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 85 | 16 |
| Warfarin Sodium | Warfarin Sodium | 84 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 83 | 23 |
| Ibuprofen | Ibuprofen | 83 | 19 |
| Atenolol | Atenolol | 81 | 15 |
| Levetiracetam | Levetiracetam | 79 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 79 | 37 |
| Dicyclomine Hcl | Dicyclomine Hcl | 78 | 13 |
| Propranolol Hcl | Propranolol Hcl | 75 | 14 |
| Glipizide | Glipizide | 73 | 14 |
| Midodrine Hcl | Midodrine Hcl | 73 | 14 |
| Naproxen | Naproxen | 73 | 17 |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 70 | 11 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 68 | 28 |
| Alprazolam | Alprazolam | 67 | 20 |
| Celecoxib | Celecoxib | 66 | 12 |
| Clonidine Hcl | Clonidine Hcl | 66 | 11 |
| Lovastatin | Lovastatin | 66 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 64 | 15 |
| Enulose | Lactulose | 64 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 64 | 17 |
| Terazosin Hcl | Terazosin Hcl | 63 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 62 | 11 |
| Levofloxacin | Levofloxacin | 62 | 46 |
| Prednisone | Prednisone | 62 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 62 | suppressed |
| Xarelto | Rivaroxaban | 61 | suppressed |
| Ondansetron Odt | Ondansetron | 57 | 33 |
| Oxybutynin Chloride | Oxybutynin Chloride | 57 | 16 |
| Chlorthalidone | Chlorthalidone | 55 | 15 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 54 | 11 |
| Bumetanide | Bumetanide | 53 | 13 |
| Methylprednisolone | Methylprednisolone | 53 | 44 |
| Cephalexin | Cephalexin | 52 | 31 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 52 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 50 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 50 | suppressed |
| Pregabalin | Pregabalin | 50 | suppressed |
| Fenofibrate | Fenofibrate | 48 | suppressed |
| Gemfibrozil | Gemfibrozil | 48 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 48 | suppressed |
| Torsemide | Torsemide | 48 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 22 |
| Doxycycline Hyclate | Doxycycline Hyclate | 47 | 32 |
| Latanoprost | Latanoprost | 47 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 47 | suppressed |
| Myrbetriq | Mirabegron | 46 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 45 | 22 |
| Amoxicillin | Amoxicillin | 45 | 35 |
| Klor-Con M20 | Potassium Chloride | 44 | 13 |
| Sucralfate | Sucralfate | 44 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 43 | 20 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 43 | 35 |
| Clonazepam | Clonazepam | 42 | suppressed |
| Topiramate | Topiramate | 42 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 41 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 40 | 29 |
| Paroxetine Hcl | Paroxetine Hcl | 40 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 38 | 16 |
| Cilostazol | Cilostazol | 38 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 38 | 11 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 38 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 38 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 38 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 37 | 35 |
| Amitriptyline Hcl | Amitriptyline Hcl | 36 | suppressed |
| Baclofen | Baclofen | 35 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 34 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 34 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 33 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 33 | 33 |
| Fluticasone Propionate | Fluticasone Propionate | 32 | 14 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 31 | suppressed |
| Ramipril | Ramipril | 30 | suppressed |
| Ranolazine Er | Ranolazine | 30 | suppressed |
| Rivastigmine | Rivastigmine | 30 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 29 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 28 | suppressed |
| Olanzapine | Olanzapine | 28 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 27 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 27 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 27 | suppressed |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 26 | suppressed |
| Sotalol | Sotalol Hcl | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 24 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Fluconazole | Fluconazole | 24 | 16 |
| Verapamil Er | Verapamil Hcl | 24 | suppressed |
| Colchicine | Colchicine | 23 | suppressed |
| Diazepam | Diazepam | 23 | suppressed |
| Nateglinide | Nateglinide | 23 | suppressed |
| Nystatin | Nystatin | 23 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 22 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 22 | 19 |
| Hydrocortisone | Hydrocortisone | 22 | suppressed |
| Niacin Er | Niacin | 22 | suppressed |
| Temazepam | Temazepam | 22 | suppressed |
| Timolol Maleate | Timolol Maleate | 22 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Loperamide | Loperamide Hcl | 21 | 14 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Levemir Flexpen | Insulin Detemir | 20 | suppressed |
| Jardiance | Empagliflozin | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 14 |
| Primidone | Primidone | 19 | suppressed |
| Levemir | Insulin Detemir | 18 | suppressed |
| Ozempic | Semaglutide | 18 | suppressed |
| Risperidone | Risperidone | 18 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 18 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 18 | suppressed |
| Cimetidine | Cimetidine | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 17 | suppressed |
| Metolazone | Metolazone | 17 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 17 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 16 | suppressed |
| Lamotrigine | Lamotrigine | 16 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 15 | 13 |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 15 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 14 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 14 | suppressed |
| Gemtesa | Vibegron | 14 | suppressed |
| Insulin Aspart | Insulin Aspart | 14 | suppressed |
| Klayesta | Nystatin | 14 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 14 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 14 | suppressed |
| Methimazole | Methimazole | 14 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 14 | 14 |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Trospium Chloride | Trospium Chloride | 14 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 14 | suppressed |
| Anastrozole | Anastrozole | 13 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 13 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Dipyridamole | Dipyridamole | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 12 | suppressed |
| Klor-Con M10 | Potassium Chloride | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Ssd | Silver Sulfadiazine | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Etodolac | Etodolac | 11 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $57.46 · 3 records | Boston Scientific Corporation | LEQVIO, OTEZLA, REPATHA, WATCHMAN Access System | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error